wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28383663-5CBC501B-53B5-470C-82BD-96796FB4D099
Q28383663-5CBC501B-53B5-470C-82BD-96796FB4D099
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28383663-5CBC501B-53B5-470C-82BD-96796FB4D099
Novel non-AR therapeutic targets in castrate resistant prostate cancer
P2860
Q28383663-5CBC501B-53B5-470C-82BD-96796FB4D099
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28383663-5CBC501B-53B5-470C-82BD-96796FB4D099
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d4f5ded0ad62b34d4049eee840d3fb64f0aea492
P2860
Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.